Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET
- 31 July 1997
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 33 (8), 1234-1241
- https://doi.org/10.1016/s0959-8049(97)00111-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Decision making in abdominal surgery following chemotherapy for testicular cancerEuropean Journal Of Cancer, 1995
- Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18- fluorodeoxyglucoseBlood, 1995
- Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose.Radiology, 1995
- Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.Radiology, 1995
- Predictors of residual mass requiring surgical resection after chemotherapy of stage III testicular cancer A prospective studyUrology, 1992
- CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded?Radiology, 1991
- Recurrence of colorectal tumors: PET evaluation.Radiology, 1989
- Physical performance of the latest generation of commercial positron scannerIEEE Transactions on Nuclear Science, 1988
- Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic ToolInvestigative Radiology, 1987
- Radiation therapy in malignant testis tumors.Part I: Seminoma; Part II: CarcinomaCancer, 1973